Explore the Latest Rivaroxaban Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Rivaroxaban Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Rivaroxaban Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Rivaroxaban Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Rivaroxaban Tenders and beyond.
14080913Chloropyramine tablets 25 mg each Desloratadine tablets 5 mg each Validol tablets of 100 mg Barbiturates in combination ethyl ether of a-bromosovaleric acid 20 mg phenobarCountry: UkraineDeadline14 Aug 20268637905Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Rivaroxaban Filmtabletten ausgenommen in der Wirkstrke 25 mg ATC B01AF01Country: GermanyDeadline03 Jul 20279062323Germany Pharmaceutical products Abschluss nicht exkl AM-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Rivaroxaban ATC-Code nach WHO B01AF01Country: GermanyDeadline30 Sep 20269108096Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Rivaroxaban nur Filmtabletten exkl Wirkstrke 25 mg ATC B01AF01Country: GermanyDeadline31 Jul 20279145124Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Rivaroxaban ATC B01AF01 - in allen Wirkstrken auer 25 mg je abgeteilte orale DarreichungsformCountry: GermanyDeadline31 Jul 202713085047Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713148981Medicines with the active ingredient rivaroxaban (ATC: B01AF01 - in all potencies except 2.5 mg per divided oral dosage form)Country: GermanyDeadline31 Jul 202713188330Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713327120Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713381709Medicines with the active ingredient rivaroxaban (ATC: B01AF01 - in all potencies except 2.5 mg per divided oral dosage form)Country: GermanyDeadline31 Jul 202713414180Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713486282Medicines with the active ingredient rivaroxaban (ATC: B01AF01 - in all potencies except 2.5 mg per divided oral dosage form)Country: GermanyDeadline31 Jul 202713502229Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713568372Medicines with the active ingredient rivaroxaban (ATC: B01AF01 - in all potencies except 2.5 mg per divided oral dosage form)Country: GermanyDeadline31 Jul 202713584576Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202713669786Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Rivaroxaban (ATC-Code: B01AF01 - in allen Wirkstärken außer 2,5 mg jCountry: GermanyDeadline26 Jun 202813687317Medicines with the active ingredient rivaroxaban (ATC: B01AF01 - in all potencies except 2.5 mg per divided oral dosage form)Country: GermanyDeadline31 Jul 202713698170Medicines - Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excluding potency 2.5 mg, ATC B01AF01Country: GermanyDeadline31 Jul 202714111872021-2015 -33600000-6 - Metamizole sodium Amitriptyline Amlodipine Allopurinol Losartan and diuretics Quetiapine Verapamil IsosCountry: UkraineDeadline15 Aug 2026
